Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ: IBB )

136.55 -0.49 (-0.36%)
Official Closing Price Updated: 4:15 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Do The Major Sector ETFs Love High Flying Stocks?
The major sector ETFs remain muted. Nothing screams wildly bullish or horribly bearish in the weekly charts. 
Via Talk Markets
Topics Cryptocurrencies ETFs
Ascendis Pharma Eyes Best Open In A Month After Q4 Print, But BofA Cuts Price Target: Retail Gets Buzzing
The brokerage adjusted its 2025 Yorvipath sales forecast downward, expecting a more backloaded ramp. 
Via Stocktwits
Price Action Disputes Most Macro Narratives
Do you believe the economy is heading towards inflation? What about a recession? Are gold prices sending a warning? Read on for the answer. 
Via Talk Markets
Topics Economy Stocks / Equities
Exposures Economy
Can Biotech Stocks Survive The Precarious Macro?
We were having a nice rally in January 2025 until the reality of tariffs hit on Friday which killed the momentum developing off the mid-January lows. 
Via Talk Markets
Topics Stocks / Equities World Trade
Exposures Tariff
Compare/Contrast - Year Of The Yin Wood Snake 1965 And 2025
The Federal debt in 1965 was $322.3 billion. In 2025 it is at $36.24 trillion. The unemployment rate was 5.2%. Now it is at 4.1%. 
Via Talk Markets
Topics ETFs
Small- To Mid-Cap Biotech Trades Poised For Gains
On Monday, we called for a trading bottom in healthcare stocks. We also saw momentum picking for two Health Science sectors: small- to mid-cap biotechs, and MedTech. Here is a closer look at these... 
Via Talk Markets
Topics ETFs Stocks / Equities
DeepSeek Is Not New - The Rotation Away From Tech Is
The technical aspect of DeepSeek is not new. The reaction to it though, is new. 
Via Talk Markets
Topics Commodities
Intellia Stock Dips After Morgan Stanley Downgrade, Retail Sentiment Weakens
The brokerage pointed to the company’s recent discontinuation of its NTLA-3001 program for alpha-1 antitrypsin deficiency-associated lung disease, reducing near-term growth prospects. 
Via Stocktwits
Healthcare And Biotech Stocks Lag The Market Again
Biotech stocks got little help from the JPM Conference despite some recovery to the general market. 
Via Talk Markets
Topics Stocks / Equities
There May Still Be Time to Get in on These 3 Trending Biotechs
Biotech firms as a group declined slightly in the last year amid a tough external environment, but these three companies could grow in 2025. 
Via MarketBeat
Topics ETFs Economy
Exposures Economy Interest Rates
Major Sector ETFs January Trend Trade is Here
Transportation IYT chart is incredible. The price action Friday showed the attempt to take out the January trend trade range and then failed. 
Via Talk Markets
Topics ETFs
Inflation, Soft Landing, January Trend Trade Working Out
Sugar, as shown in the weekly chart, has broken down under the 200-WMA for the first time since December 2020. However, it is holding the August 2024 low. 
Via Talk Markets
Topics Commodities ETFs Economy
Exposures Interest Rates
Avadel Pharmaceuticals Misses Earnings Estimates But Posts 150% Sales Increase From Narcolepsy Drug LUMRYZ
Avadel Pharmaceuticals missed the fourth quarter sales estimate by 5.12%. Still, the sales of its narcolepsy drug, LUMRYZ rose by 150% YoY. 
Via Benzinga
The Major Sector ETFs Remain Technically Intact
As long as XRT holds 78.00, it’s back where it broke out from after a massive consolidation last year. 
Via Talk Markets
Topics Cryptocurrencies ETFs
Two Big Weeks To Play A Rally In Biotech And Healthcare Stocks
The healthcare sector is lagging over the past year and recent quarter with the XLV flat for 2024 and down over 4% for the recent quarter. 
Via Talk Markets
Topics ETFs Stocks / Equities
Happy New Year Or Is It For The Major Sector ETFs?
Russell 2000 IWM, has a few key points of support to hold. $217 is one. The 50-week moving average at around $212.45 is another. 
Via Talk Markets
Topics ETFs
Healthcare And Biotech Stocks Continue Their Slide
Biotech shares continued their slide which began in early November and got no help from small caps which also sold off through December. 
Via Talk Markets
Topics ETFs Stocks / Equities
Major Sector ETFs - Buy This Dip?
​​​​​​​As we ended this week, clearly Nasdaq held up better than pretty much everything else. 
Via Talk Markets
Topics Commodities ETFs
The Major Sector ETFs Talk Turkey
Retail XRT should hold the gap up it started this past week with. If that is the case, we anticipate a move higher for the coming week. 
Via Talk Markets
Topics Currencies/Forex ETFs
Momentum Model For Trading SMID Biotech Stocks: Broad Rally Underway
Biotech stocks are poised for a recovery in a seasonally strong period through January 2025. 
Via Talk Markets
Topics ETFs Stocks / Equities
Major Sector ETFs - Retail Rallies
What we waited for was a weekly close over 79.20, a level we have not seen since February 2022. 
Via Talk Markets
Topics Cryptocurrencies ETFs
Is Biotech’s Bull Run Over? Examining Election Impacts
The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup. 
Via MarketBeat
Topics ETFs Government
Exposures Political
Cameco, Applied Digital, West Pharmaceutical And More On CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Tim Seymour of Seymour Asset Management picked Cameco Corporation. 
Via Benzinga
Reality Sets Into The Major Sector ETFs
XRT failed to rally above the $80 level, the top of the 10-month consolidation. 
Via Talk Markets
What Do Major Sector ETFs Say Now?
KRE is back to the scene of the crime at the 65 level. Above there, we see 75 area as the next resistance. 
Via Talk Markets
Topics ETFs
What Does the Economic Modern Family Say Now?
Considering where the Economic Modern Family was just a few weeks ago, clearly euphoria has spread since the election. 
Via Talk Markets
Smaller Cap Biotechs Are In Season: How Are We Doing?
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
Via Talk Markets
Stock And Commodity Market Thoughts
As the SPY corrects a bit from the recent run up to all-time highs, we still have keen eyes on other sectors. 
Via Talk Markets
Healthcare Sector Update: Choppy Days Are Here Again As Yields Rise
There has been a shift in healthcare stock performance by sub-sector which should be confirmed as we move through the Q3 earnings cycle. 
Via Talk Markets
Can Biotechnology Make A Seasonal Move Higher?
Currently, IBB trades beneath the July calendar range high. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.